Evidence map›Paper›PMID 26831916›Full record

ArticleJAMA internal medicine2016

Association Between Lifetime Marijuana Use and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Reto Auer, Eric Vittinghoff, Kristine Yaffe, Arnaud Künzi, Stefan G Kertesz, Deborah A Levine, Emiliano Albanese, Rachel A Whitmer, David R Jacobs, Stephen Sidney and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in JAMA internal medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
22.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 146 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Multi-Modal Cannabis Use Among U.S. Young Adults: Findings from the 2022 and 2023 BRFSS in 23 States.International journal of environmental research and public health · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Reto AuerDepartment of Epidemiology and Biostatistics, University of California-San Francisco2Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland.
Eric VittinghoffDepartment of Epidemiology and Biostatistics, University of California-San Francisco.
Kristine YaffeDepartment of Epidemiology and Biostatistics, University of California-San Francisco3Department of Psychiatry and Neurology, University of California-San Francisco.
Arnaud KünziDepartment of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland.
Stefan G KerteszCenter for Surgical Medical and Acute Care Research, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama5Department of Medicine, University of Alabama at Birmingham School of Medicine.
Deborah A LevineDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor7Veterans Affairs Center for Clinical Management Research, Ann Arbor, Michigan8Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor9Department of.
Emiliano AlbaneseDepartment of Psychiatry, University of Geneva, Geneva, Switzerland.
Rachel A WhitmerKaiser Permanente Division of Research, Oakland, California.
David R JacobsDivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis.
Stephen SidneyKaiser Permanente Division of Research, Oakland, California.
M Maria GlymourDepartment of Epidemiology and Biostatistics, University of California-San Francisco.
Mark J PletcherDepartment of Epidemiology and Biostatistics, University of California-San Francisco.
University of California, San Francisco · USKaiser Permanente · USUniversity of Alabama at Birmingham · USUniversity of Geneva · CHUniversity of Lausanne · CHUniversity of Minnesota · USVA Center for Clinical Management Research · US

Funding

NHLBI NIH HHS HHSN268200900041CNHLBI NIH HHS HHSN268201300025CNHLBI NIH HHS HHSN268201300026CNHLBI NIH HHS HHSN268201300027CNHLBI NIH HHS HHSN268201300028CNHLBI NIH HHS HHSN268201300029C
6 · The paper itself

Abstract

importanceMarijuana use is increasingly common in the United States. It is unclear whether it has long-term effects on memory and other domains of cognitive function.

objectiveTo study the association between cumulative lifetime exposure to marijuana use and cognitive performance in middle age. DESIGN, SETTING, AND

participantsWe used data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, a cohort of 5115 black and white men and women aged 18 to 30 years at baseline from March 25, 1985, to June 7, 1986 (year 0), and followed up over 25 years from June 7, 1986, to August 31, 2011, to estimate cumulative years of exposure to marijuana (1 year = 365 days of marijuana use) using repeated measures and to assess associations with cognitive function at year 25. Linear regression was used to adjust for demographic factors, cardiovascular risk factors, tobacco smoking, use of alcohol and illicit drugs, physical activity, depression, and results of the mirror star tracing test (a measure of cognitive function) at year 2. Data analysis was conducted from June 7, 1986, to August 31, 2011. MAIN OUTCOMES AND MEASURES: Three domains of cognitive function were assessed at year 25 using the Rey Auditory Verbal Learning Test (verbal memory), the Digit Symbol Substitution Test (processing speed), and the Stroop Interference Test (executive function).

resultsAmong 3385 participants with cognitive function measurements at the year 25 visit, 2852 (84.3%) reported past marijuana use, but only 392 (11.6%) continued to use marijuana into middle age. Current use of marijuana was associated with worse verbal memory and processing speed; cumulative lifetime exposure was associated with worse performance in all 3 domains of cognitive function. After excluding current users and adjusting for potential confounders, cumulative lifetime exposure to marijuana remained significantly associated with worse verbal memory. For each 5 years of past exposure, verbal memory was 0.13 standardized units lower (95% CI, -0.24 to -0.02; P = .02), corresponding to a mean of 1 of 2 participants remembering 1 word fewer from a list of 15 words for every 5 years of use. After adjustment, we found no associations with lower executive function (-0.03 [95% CI, -0.12 to 0.07]; P = .56) or processing speed (-0.04 [95% CI, -0.16 to 0.08]; P = .51). CONCLUSIONS AND RELEVANCE: Past exposure to marijuana is associated with worse verbal memory but does not appear to affect other domains of cognitive function.

Indexed as

CognitionExecutive FunctionMemoryAdultCannabisCoronary Artery DiseaseDrug UsersFemaleHumansLongitudinal StudiesMaleMiddle AgedRisk FactorsUnited StatesVerbal LearningYoung Adult

Identifiers

PMID26831916
PMCPMC5109019
OpenAlexW2257073238

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.